Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)

Recruiting now

Conditions studied: Neuroblastic Tumors

In brief

To describe the natural history of peripheral neuroblastic tumour presenting with SCI and evaluate the combined effects of different risk factors on the eventual neurologic and orthopaedic outcomes

Key facts

Study ID

NCT02559804

Run by

Associazione Italiana Ematologia Oncologia Pediatrica

People needed

150

Starts

2014-05-01

Expected to finish

2029-05-01

Last updated by the study team

2024-04-15

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of peripheral neuroblastic tumour - peripheral neuroblastic tumour (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) presenting with SCI, symptomatic or asymptomatic, independent of disease extension (stage), and clinical course (first diagnosis or relapse/progression)
• No previous chemotherapy, except steroids, in the last 6 months
• Age <18 years
• Minimal planned follow-up of 5 years
• Parent/patient written informed consent (Appendix 1(A,B,C))

You may not qualify if…

• Invasion of intervertebral foramina only

Where it is running

• Istituto Giannina Gaslini — Genova, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.